PMID- 28883243
OWN - NLM
STAT- MEDLINE
DCOM- 20180402
LR  - 20181202
IS  - 1349-7235 (Electronic)
IS  - 0918-2918 (Print)
IS  - 0918-2918 (Linking)
VI  - 56
IP  - 19
DP  - 2017 Oct 1
TI  - An HIV-positive Case of Obstructive Jaundice Caused by Immune Reconstitution 
      Inflammatory Syndrome of Tuberculous Lymphadenitis Successfully Treated with 
      Corticosteroids.
PG  - 2661-2666
LID - 10.2169/internalmedicine.8713-16 [doi]
AB  - A 60-year-old man was admitted to our hospital because of a persistent fever with 
      enlargement of multiple lymph nodes in the mediastinum and around the pancreatic 
      head. He was diagnosed with tuberculosis and human immunodeficiency virus 
      infection. We started antiretroviral therapy three weeks after the initiation of 
      anti-tuberculous therapy. Two weeks later, jaundice appeared with dilatation of 
      the biliary tract due to further enlargement of the lymph nodes, which seemed to 
      be immune reconstitution inflammatory syndrome (IRIS). The administration of 
      corticosteroids resolved the obstructive jaundice without surgical treatment or 
      endoscopic drainage. Obstructive jaundice caused by IRIS should first be treated 
      with corticosteroids before invasive treatment.
FAU - Watanabe, Naoaki
AU  - Watanabe N
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Sato, Ryota
AU  - Sato R
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Nagai, Hideaki
AU  - Nagai H
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Matsui, Hirotoshi
AU  - Matsui H
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Yamane, Akira
AU  - Yamane A
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Kawashima, Masahiro
AU  - Kawashima M
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Suzuki, Junko
AU  - Suzuki J
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Tashimo, Hiroyuki
AU  - Tashimo H
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Ohshima, Nobuharu
AU  - Ohshima N
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Masuda, Kimihiko
AU  - Masuda K
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Tamura, Atsuhisa
AU  - Tamura A
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Akagawa, Shinobu
AU  - Akagawa S
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Hebisawa, Akira
AU  - Hebisawa A
AD  - Department of Clinical Research, National Hospital Organization Tokyo National 
      Hospital, Japan.
FAU - Ohta, Ken
AU  - Ohta K
AD  - Center for Pulmonary Diseases, National Hospital Organization Tokyo National 
      Hospital, Japan.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20170906
PL  - Japan
TA  - Intern Med
JT  - Internal medicine (Tokyo, Japan)
JID - 9204241
RN  - 0 (Adrenal Cortex Hormones)
RN  - 0 (Anti-Retroviral Agents)
SB  - IM
MH  - Adrenal Cortex Hormones/*therapeutic use
MH  - Anti-Retroviral Agents/*therapeutic use
MH  - HIV Infections/complications/*drug therapy
MH  - HIV Seropositivity/complications
MH  - Humans
MH  - Immune Reconstitution Inflammatory Syndrome/*complications/diagnosis/*drug 
      therapy
MH  - Jaundice, Obstructive/*drug therapy/etiology
MH  - Lymph Nodes/pathology
MH  - Male
MH  - Middle Aged
MH  - Treatment Outcome
MH  - Tuberculosis, Lymph Node/*drug therapy
PMC - PMC5658536
OTO - NOTNLM
OT  - HIV
OT  - immune reconstitution inflammatory syndrome
OT  - obstructive jaundice
OT  - tuberculous lymphadenitis
EDAT- 2017/09/09 06:00
MHDA- 2018/04/03 06:00
PMCR- 2017/10/01
CRDT- 2017/09/09 06:00
PHST- 2017/09/09 06:00 [pubmed]
PHST- 2018/04/03 06:00 [medline]
PHST- 2017/09/09 06:00 [entrez]
PHST- 2017/10/01 00:00 [pmc-release]
AID - 10.2169/internalmedicine.8713-16 [doi]
PST - ppublish
SO  - Intern Med. 2017 Oct 1;56(19):2661-2666. doi: 10.2169/internalmedicine.8713-16. 
      Epub 2017 Sep 6.